Search research articles
Contact Us
Filters
Showing results (51-60 of 76) with videos related to
Page
of 8
Sort By:
Clinics and Research in Hepatology and Gastroenterology
|
February 1, 2015
Early virological assessment during telaprevir- or boceprevir-based triple therapy in hepatitis C cirrhotic patients who failed a previous interferon based regimen - The ANRS CO20-CUPIC study
François Bailly, Victor Virlogeux, Cécilie Dufour, et al.
Gastrointestinal Endoscopy
|
October 22, 2023
Prevalence and clinical significance of the muscle retracting sign during endoscopic submucosal dissection of large macronodular colorectal lesions (with videos)
Jérémie Albouys, Imane Manzah, Marion Schaefer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 12, 2024
Direct Antivirals Can Achieve a Cure in All Patients With Chronic Hepatitis C due to Genotype 5: A French Multicentre Study
Carine Nicolas, Quentin Domas, Stanislas Pol, et al.
Journal of Viral Hepatitis
|
January 3, 2023
Towards hepatitis C elimination in France: Scanvir, an effective model to test and treat drug users on dedicated days
Marilyne Debette-Gratien, Sandrine François, Catherine Chevalier, et al.
European Journal of Gastroenterology & Hepatology
|
December 23, 2017
Efficacy of daclatasvir-based quadruple therapy in nonresponder patients infected by hepatitis C virus genotype 4: the ANRS HC32 QUATTRO study
Dominique Roulot, Vincent Thibault, Claire Laforest, et al.
Journal of Hepatology
|
November 8, 2021
A simple clinical score to promote and enhance ferroportin disease screening
Amandine Landemaine, Houda Hamdi-Roze, Séverine Cunat, et al.
Journal of Gastroenterology and Hepatology
|
March 19, 2016
Different precore/core mutations of hepatitis B interact with, limit, or favor liver fibrosis severity
Alexandra Ducancelle, Adeline Pivert, Sandrine Bertrais, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
November 15, 2017
Pharmacokinetics-Based Adjusted Versus Standard Dose of Ribavirin Does Not Improve Virologic Response Rates in Chronic Hepatitis C Genotype 4 Patients: A Randomized Controlled Trial
Ibrahim H Altraif, Faisal Sanai, Mohammed A Babatin, et al.
European Journal of Gastroenterology & Hepatology
|
April 29, 2024
Hepatitis B Delta: assessment of the knowledge and practices of hepato-gastroenterologists practicing in non-academic settings in France
Jean-François D Cadranel, Honoré T Zougmoré, Jean-René Ngele Efole, et al.
The Oncologist
|
December 16, 2018
Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell Lymphomas
Michele Merli, Marco Frigeni, Laurent Alric, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 76) with videos related to
Sort By:
Page
of 8
Clinics and Research in Hepatology and Gastroenterology
|
February 1, 2015
Early virological assessment during telaprevir- or boceprevir-based triple therapy in hepatitis C cirrhotic patients who failed a previous interferon based regimen - The ANRS CO20-CUPIC study
François Bailly, Victor Virlogeux, Cécilie Dufour, et al.
Gastrointestinal Endoscopy
|
October 22, 2023
Prevalence and clinical significance of the muscle retracting sign during endoscopic submucosal dissection of large macronodular colorectal lesions (with videos)
Jérémie Albouys, Imane Manzah, Marion Schaefer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 12, 2024
Direct Antivirals Can Achieve a Cure in All Patients With Chronic Hepatitis C due to Genotype 5: A French Multicentre Study
Carine Nicolas, Quentin Domas, Stanislas Pol, et al.
Journal of Viral Hepatitis
|
January 3, 2023
Towards hepatitis C elimination in France: Scanvir, an effective model to test and treat drug users on dedicated days
Marilyne Debette-Gratien, Sandrine François, Catherine Chevalier, et al.
European Journal of Gastroenterology & Hepatology
|
December 23, 2017
Efficacy of daclatasvir-based quadruple therapy in nonresponder patients infected by hepatitis C virus genotype 4: the ANRS HC32 QUATTRO study
Dominique Roulot, Vincent Thibault, Claire Laforest, et al.
Journal of Hepatology
|
November 8, 2021
A simple clinical score to promote and enhance ferroportin disease screening
Amandine Landemaine, Houda Hamdi-Roze, Séverine Cunat, et al.
Journal of Gastroenterology and Hepatology
|
March 19, 2016
Different precore/core mutations of hepatitis B interact with, limit, or favor liver fibrosis severity
Alexandra Ducancelle, Adeline Pivert, Sandrine Bertrais, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
November 15, 2017
Pharmacokinetics-Based Adjusted Versus Standard Dose of Ribavirin Does Not Improve Virologic Response Rates in Chronic Hepatitis C Genotype 4 Patients: A Randomized Controlled Trial
Ibrahim H Altraif, Faisal Sanai, Mohammed A Babatin, et al.
European Journal of Gastroenterology & Hepatology
|
April 29, 2024
Hepatitis B Delta: assessment of the knowledge and practices of hepato-gastroenterologists practicing in non-academic settings in France
Jean-François D Cadranel, Honoré T Zougmoré, Jean-René Ngele Efole, et al.
The Oncologist
|
December 16, 2018
Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell Lymphomas
Michele Merli, Marco Frigeni, Laurent Alric, et al.
Page
of 8